N0937 (Alliance): Preliminary results of a phase II clinical trial of cisplatin and the novel agent brostallicin in patients with metastatic triple negative breast cancer (mTNBC)
   Google Scholar   
Citation:
Cancer Res vol 72 (24 Suppl) P1-12-06
Meeting Instance:
AACR 2012
Year:
2012
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                   
Networks:
 
Study
NCCTG-N0937
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: